In fact, demonstrating a rearrangement of MYB, MYBL1, PLAG1, HMGA2, NTRK3, and a BRAF mutation in the appropriate morphological context is diagnostic of adenoid cystic carcinoma, cutaneous mixed tumor, secretory carcinoma, syringocystadenoma papilliferum, and tubular adenoma. Here, MYB is linked to syringocystadenoma papilliferum.